Here are 5 things individuals should know about the powerful impact of blood donation and the benefits becoming a donor can ...

The long-term safety of ibrutinib was proven in patients with newly diagnosed or relapsed or refractory (R/R) chronic ...

The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...

Saad Z. Usmani, MD, MBA, FACP, discusses how the CEPHEUS study, presented at ASH 2024, along with its expanded analysis of minimal residual disease (MRD) outcomes, provides valuable insights into the ...

Saad Z. Usmani, MD, MBA, FACP, discusses how the definition of the transplant-ineligible population for multiple myeloma is evolving while also addressing the challenges of standardizing minimal ...

Trial confirms elinzanetant's efficacy and safety in addressing vasomotor symptoms caused by adjuvant endocrine therapy in ...

The bird flu, also known as avian influenza and H5N1, was implicated in the first human death from the infectious disease on ...

Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian ...

Mistrust in health care, concerns over safety, and ineffective communication surrounding vaccines were among the themes ...

Vitiligo, a skin condition causing depigmentation, may significantly increase the risk of serious cardiovascular events.

Outcomes and care related to stroke in London, United Kingdom, were notably different based on ethnicity, with major ...

Patients with multiple myeloma (MM) can experience diminished immune responses during prolonged treatment; however, mRNA ...